Santen Pharmaceutical Co Ltd
TSE:4536
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Santen Pharmaceutical Co Ltd
Santen Pharmaceutical Co Ltd
Other Equity
Santen Pharmaceutical Co Ltd
Other Equity Peer Comparison
4502
4568
4578
4519
4503
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Santen Pharmaceutical Co Ltd
TSE:4536
|
Other Equity
¥48.4B
|
CAGR 3-Years
76%
|
CAGR 5-Years
55%
|
CAGR 10-Years
18%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Other Equity
¥2.5T
|
CAGR 3-Years
98%
|
CAGR 5-Years
48%
|
CAGR 10-Years
20%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Other Equity
¥284B
|
CAGR 3-Years
37%
|
CAGR 5-Years
20%
|
CAGR 10-Years
9%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Other Equity
¥249.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
23%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Other Equity
¥2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-8%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Other Equity
¥533.3B
|
CAGR 3-Years
47%
|
CAGR 5-Years
29%
|
CAGR 10-Years
14%
|
See Also
What is Santen Pharmaceutical Co Ltd's Other Equity?
Other Equity
48.4B
JPY
Based on the financial report for Mar 31, 2024, Santen Pharmaceutical Co Ltd's Other Equity amounts to 48.4B JPY.
What is Santen Pharmaceutical Co Ltd's Other Equity growth rate?
Other Equity CAGR 10Y
18%
Over the last year, the Other Equity growth was 64%. The average annual Other Equity growth rates for Santen Pharmaceutical Co Ltd have been 76% over the past three years , 55% over the past five years , and 18% over the past ten years .
You don't have any saved screeners yet
